Psych MEQs / SAQs · Professional — formulation
MEQ: BPS and 4P formulation for first-episode psychosis with cannabis
FRANZCP-style MEQ requiring definition of formulation vs diagnosis, a full BPS×4P matrix for FEP with cannabis, mapped management plan, and evidence anchors (Engel/Macneil/Owen/CFI).
On this page & tools
Target exams
Model answer
Reveal model answer
(i) Definition and distinction (3). Psychiatric case formulation is a hypothesis-driven, individualised explanatory account of why this person has these problems now, integrating multi-domain data to guide intervention and communication. Diagnosis classifies a syndrome for communication, epidemiology, and evidence application. Diagnosis is necessary but not sufficient for personalised care; formulation bridges generic evidence and the individual without replacing risk or capacity assessment.[1][2]
(ii) BPS × 4P formulation (8).
[1][2]Presenting problem. First-episode psychosis (positive symptoms, functional collapse) with heavy cannabis use and family conflict; differential remains open to substance-induced and other organic contributions pending work-up.
[1][2]Predisposing. Biological: first-degree family history of schizophrenia (genetic vulnerability). Psychological: possible pre-morbid social vulnerability (implied by rapid isolation under stress). Social: developmental context to be expanded; structural student stress.
[1][2]Precipitating. Daily high-potency cannabis; severe sleep restriction in exam week; academic stress as tip-over context.
[1][2]Perpetuating. Ongoing cannabis; sleep debt; untreated psychosis; social withdrawal; parental high expressed emotion / conflicting illness explanations that may increase stress and reduce consistent support.
[1][2]Protective. Engaged sister; still attending (brought to clinic); university role as potential future scaffold; absence of described forensic violence history in stem (still assess risk fully).
[1][2]Mechanisms (brief). Diathesis (family loading) + cannabis/sleep stress lowered psychosis threshold; positive symptoms and paranoia drive withdrawal; withdrawal and family conflict maintain arousal and reduce reality-testing opportunities; competing explanatory models (spirits vs system) affect help-seeking and alliance.[1][2][3]
(iii) Mapped plan (6).
[1][2]- Biological: medical/organic screen appropriate to FEP; discuss antipsychotic trial targeting positive symptoms and sleep restoration; cannabis psychoeducation and harm-reduction/cessation support; sleep interventions.
- Psychological: psychoeducation about psychosis; collaborative formulation in plain language; CBT for psychosis elements when engagement allows; motivational work for cannabis.
- Social/family: family psychoeducation to lower EE and align a shared illness model; involve sister as support; education/university liaison when stable; practical supports.
- Cultural/meaning: explore illness explanations (spirits/system) with curiosity (CFI-style); do not ridicule; negotiate a shared care plan that respects meaning while offering medical model as additional frame.
- Risk: full suicide/violence/vulnerability assessment; safety plan; intensity of follow-up matched to risk and supports; least-restrictive setting that is safe.
- Review: rewrite formulation after abstinence attempt, treatment response, and collateral.[1][4][5]
(iv) Evidence anchors (3). Examples: Engel on biopsychosocial levels; Macneil et al. on formulation beyond diagnosis; Owen on what formulation is; Lewis-Fernández CFI field trial / OCF operationalisation for cultural assessment.[1][2][3][4]
Common errors
Restating “schizophrenia” as the whole formulation; omitting protective factors; blaming parents without specifying EE/conflict mechanisms; ignoring cannabis/sleep as multi-role factors; no plan map; mocking spiritual explanatory models; inventing mental health act section numbers; delaying organic work-up because the story “sounds functional.”[1][2][5]
References
- [1]Macneil CA, Hasty MK, Conus P, et al. Is diagnosis enough to guide interventions in mental health? Using case formulation in clinical practice BMC Med, 2012.PMID 23016556
- [2]Owen G What is formulation in psychiatry? Psychol Med, 2023.PMID 36878884
- [3]Engel GL The need for a new medical model: a challenge for biomedicine Science, 1977.PMID 847460
- [4]Lewis-Fernández R, Aggarwal NK, Lam PC, et al. Feasibility, acceptability and clinical utility of the Cultural Formulation Interview: mixed-methods results from the DSM-5 international field trial Br J Psychiatry, 2017.PMID 28104738
- [5]Lewis-Fernández R, Aggarwal NK, Bäärnhielm S, et al. Culture and psychiatric evaluation: operationalizing cultural formulation for DSM-5 Psychiatry, 2014.PMID 24865197